Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma
Autor: | Grzegorz Fojecki, Guido Giusti, Anders Magnusson, Palle Jørn Sloth Osther, Georg Jaremko, Joyce Baard, Christian Seitz, Olivier Traxer, Thomas Knoll, Marianne Brehmer |
---|---|
Přispěvatelé: | Uppsala University Hospital, CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université (SU), University of Amsterdam [Amsterdam] (UvA), VU University Medical Center [Amsterdam], University of Southern Denmark (SDU), Karolinska University Hospital [Stockholm], Medizinische Universität Wien = Medical University of Vienna, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS San Raffaele Pisana), Karolinska Institutet [Stockholm], Graduate School, Urology, ACS - Atherosclerosis & ischemic syndromes, APH - Personalized Medicine, APH - Quality of Care, CCA - Imaging and biomarkers |
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Nephrology
medicine.medical_specialty Urology Biopsy 030232 urology & nephrology [SDV.CAN]Life Sciences [q-bio]/Cancer Ct urography [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology UTUC 03 medical and health sciences 0302 clinical medicine Risk Factors Internal medicine CT urography Urologi och njurmedicin Carcinoma Ureteral Neoplasms/diagnosis Ureteroscopy Medicine Humans Diagnostic samples Urology and Nephrology Diagnostics Kidney Neoplasms/diagnosis Upper urinary tract Urothelial carcinoma Sweden Carcinoma Transitional Cell medicine.diagnostic_test business.industry Ureteral Neoplasms General surgery Diagnostic Techniques Urological Carcinoma Transitional Cell/diagnosis medicine.disease Topic Paper Prognosis Kidney Neoplasms 3. Good health Upper tract Upper tract urothelial carcinoma 030220 oncology & carcinogenesis Practice Guidelines as Topic business |
Zdroj: | World Journal of Urology World Journal of Urology, Springer Verlag, 2019, 37 (11), pp.2271-2278. ⟨10.1007/s00345-019-02732-8⟩ World journal of urology, 37(11), 2271-2278. Springer Verlag Fojecki, G, Magnusson, A, Traxer, O, Baard, J, Osther, P J S, Jaremko, G, Seitz, C, Knoll, T, Giusti, G & Brehmer, M 2019, ' Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma ', World Journal of Urology, vol. 37, no. 11, pp. 2271-2278 . https://doi.org/10.1007/s00345-019-02732-8 |
ISSN: | 0724-4983 1433-8726 |
DOI: | 10.1007/s00345-019-02732-8⟩ |
Popis: | PURPOSE: To summarize knowledge on upper urinary tract carcinoma (UTUC) regarding diagnostic procedures, risk factors and prognostic markers.METHODS: A scoping review approach was applied to search literature in Pubmed, Web of Science, and Embase. Consensus was reached through discussions at Consultation on UTUC in Stockholm, September 2018.RESULTS: Tumor stage and grade are the most important prognostic factors. CT urography (CTU) including corticomedullary phase is the preferred imaging modality. A clear tumor on CTU in combination with high-grade UTUC in urine cytology identifies high-risk UTUC, and in some cases indirect staging can be obtained. Bladder urine cytology has limited sensitivity, and in most cases ureterorenoscopy (URS) with in situ samples for cytology and histopathology are mandatory for exact diagnosis. Image-enhancing techniques, Image S1 and narrow-band imaging, may improve tumor detection at URS. Direct confocal laser endomicroscopy may help to define grade during URS. There is strong correlation between stage and grade, accordingly correct grading is crucial. The correlation is more pronounced using the 1999 WHO than the 2004 classification: however, the 1999 system risks greater interobserver variability. Using both systems is advisable. A number of tissue-based molecular markers have been studied. None has proven ready for use in clinical practice.CONCLUSIONS: Correct grading and staging of UTUC are mandatory for adequate treatment decisions. Optimal diagnostic workup should include CTU with corticomedullary phase, URS with in situ cytology and biopsies. Both WHO classification systems (1999 and 2004) should be used to decrease risk of undergrading or overtreatment. |
Databáze: | OpenAIRE |
Externí odkaz: |